Fig. 8

Expression of ANKRD29 and TDO2 in patients with PD, BC and controls. (a) qRT-PCR results show the mRNA expression levels of IL-1β, IL-6 and IL-8 in the gingivae of individuals in the healthy and PD groups (ncon = 7, ncase = 9, respectively). GAPDH was used for normalisation relative to the control group. (b) qRT-PCR results show the mRNA expression levels of ANKRD29 and TDO2 in the gingivae of individuals in the healthy and PD groups (ncon = 7, ncase = 9, respectively). GAPDH was used for normalisation relative to the control group. (c) qRT-PCR results show the mRNA expression of ANKRD29 and TDO2 in adjacent normal tissues and BC tissues (ncon = 6, ncase = 6). GAPDH was used for normalisation relative to the control group. (d) Immunohistochemistry staining of ANKRD29 and TDO2 in the gingivae of individuals in the healthy and PD groups and in BC and healthy tissues. PD: periodontitis; BC: breast cancer; Con, control.